Olivier Touboul, Vincent Algalarrondo, Silvia Oghina, Nathalie Elbaz, Segolene Rouffiac, David Hamon, Fabrice Extramiana, Estelle Gandjbakhch, Thomas D'Humieres, Eloi Marijon, Tarvinder S Dhanjal, Emmanuel Teiger, Thibaud Damy, Nicolas Lellouche
AIMS: Atrial fibrillation (AF)/atrial flutter is common during cardiac amyloidosis (CA). Electrical cardioversion (EC) is a strategy to restore sinus rhythm (SR). However, left atrial thrombus (LAT) represents a contraindication for EC. CA patients with AF/atrial flutter have a high prevalence of LAT. We aimed to evaluate EC characteristics, LAT prevalence and risk factors, and AF/atrial flutter outcome in CA patients undergoing EC, predominantly treated with direct oral anticoagulants (DOACs)...
July 28, 2022: ESC Heart Failure